Author Correction: Venous thromboembolism and intracranial hemorrhage in patients undergoing glioblastoma surgery

Abstract

Full text

Correction to: Scientific Reports 10.1038/s41598-023-48542-2, published online 07 December 2023

The original version of this Article contained errors. An older version of the Table 1 and 3 was erroneously uploaded with an incorrect bigger subgroup of patients. The correct group size is 222 patients. As the result of this error, column ‘Total’ was removed from the tables.

The original Table 1 and 3 and accompanying legends appear below.Table 1. Baseline data, risk factors and outcome in patients with and without PH (postoperative intracranial hemorrhage).Characteristics^1^Total (N = 331)ICH (N = 13)No ICH (N = 318)p value^2^Sex (female)127 (38.4%)4 (30.8%)123 (38.7%)0.773Age (years)64.29 ± 12.6568.69 ± 9.1364.11 ± 12.750.240BMI (kg/m^2^)26.20 ± 426.17 ± 4.0326.20 ± 4.010.838Smoker50 (15.3%)050 (15.9%)0.231Diabetes45 (13.6%)2 (15.4%)43 (13.5%)0.629Hypertension195 (58.9%)9 (69.2%)186 (58.5%)0.570Atrial fibrillation23 (6.9%)1 (7.7%)22 (6.9%)1.00Previous resection87 (26.3%)2 (15.4%)85 (26.7%)0.526Therapeutic AC in patient medication22 (6.6%)1 (7.7%)21 (6.6%)0.598Anti-platelet-therapy in patient medication43 (13.2%)1 (8.3%)42 (13.4%)1.00American Society of Anesthesiologists Score < 3193 (59.2%)8 (61.5%)185 (59.1%)1.00Preoperative prophylactic AC with LMWH244 (76.7%)10 (76.9%)234 (76.7%)1.00Preoperative prophylactic AC with LMWH (Hours)22.66 ± 12.4922.10 ± 11.9522.68 ± 12.530.274Extent of resection (biopsy)45 (13.8%)2 (16.7%)43 (13.7%)0.674Duration of surgery (minutes)226.94 ± 101.91280.17 ± 159.45224.92 ± 98.900.368Lowest body temperature intraoperatively (°C)36.05 ± .4935.77 ± .4436.07 ± .490.028Blood products intraoperatively6 (1.8%)2 (15.4%)4 (1.3%)0.020Highest sys. blood pressure intraoperatively (mmHg)133.67 ± 18.23144.62 ± 30.72133.21 17.45.295Initiation of prophylactic AC after surgery (hours)34.09 ± 15.0254.50 ± 25.2833.43 ± 14.16 < .001Time spend at intensive care unit (hours)53.95 ± 86.85206.15 ± 182.1947.68 ± 74.79 < .001Thromboembolic event8 (2.4%)3 (23.1%)5 (1.6%).002Therapeutic AC within seven days after surgery13 (3.9%)3 (23.1%)10 (3.1%).011Cardiopulmonary resuscitation5 (1.5%)1 (7.7%)4 (1.3%).183In-hospital mortality16 (4.8%)1 (7.7%)15 (4.7%).481Death within 30 days22 (7.2%)2 (20%)20 (6.8%).157Death within three months55 (19.5%)3 (33.3%)52 (19.0%).384Modified Rankin Scale at discharge < 4217 (65.8%)4 (30.8%)213 (67.2%).013Modified Rankin Scale at three months < 4157 (60.6%)3 (33.3%)154 (61.6%).161BMI body mass index, LMWH low molecular weight heparine, AC anticoagulation.^1^Categorical variables are presented with the number and percentage of patients to whom the characteristic applies, Continuous variables are presented with the mean ± the standard deviation.^2^Categorical variables are calculated using Fisher's exact test (2-sided); Continuous variables are calculated using Mann–Whitney U test (2-sided).Table 3. Baseline data, risk factors and outcome in patients with and without postoperative thromboembolic event (TE).Characteristics^1^Total(N = 331)VTE(N = 8)No VTE (N = 323)p-value^3^Sex (female)127 (38.4%)3 (37.5%)124 (38.4%)1.00Age (years)64.29 ± 12.6568.75 ± 9.9064.18 ± 12.70.351BMI (kg/m^2^)26.20 ± 429.28 ± 3.1526.12 ± 4.00.013Smoker50 (15.3%)050 (15.7%).613Diabetes45 (13.6%)2 (25%)43 (13.3%).298Hypertension195 (58.9%)6 (75%)189 (58.5%).479Atrial fibrillation23 (6.9%)023 (7.1%)1.00Previous resection87 (26.3%)087 (26.9%).116Leg paresis before surgery64 (19.5%)2 (25%)62 (19.4%).656Therapeutic AC in patient medication22 (6.6%)022 (6.8%)1.00Anti-platelet-therapy in patient medication43 (13.2%)2 (25%)41 (12.9%).285American Society of Anesthesiologists Score < 3193 (59.2%)4 (50%)189 (59.4%).720Preoperative prophylactic AC with LMWH244 (76.7%)6 (75%)238 (76.8%)1.00Preoperative prophylactic AC with LMWH (hours)22.66 ± 12.4925.00 ± 14.1122.60 ± 12.47.726Extent of resection (biopsy)45 (13.8%)1 (12.5%)44 (13.8%)1.00Abdominal positioning intraoperatively30 (9.1%)1 (12.5%)29 (9.1%)1.00Duration of surgery (minutes)226.94 ± 101.91292.88 ± 163.11225.29 ± 99.75.198Duration of surgery (PE, minutes)^2^226.94 ± 101.91340.50 ± 153.63224.82 ± 99.83.042Initiation of prophylactic AC after surgery (hours)34.09 ± 15.0231.50 ± 13.3334.12 ± 15.05.494Time spend at Intensive Care Unit (hours)53.95 ± 86.85127.25 ± 172.9152.12 ± 83.30.313Therapeutic AC within seven days after surgery10 (3%)2 (25%)8 (2.5%).021Lysis Therapy within seven days after surgery2 (0.6%)2 (25%)0 (0%) < .001Intracranial hemorrhage13 (3.9%)3 (37.5%)10 (3.1%).002Cardiopulmonary resuscitation5 (1.5%)3 (37.5%)2 (0.6%) < .001In-hospital mortality16 (4.8%)2 (25%)14 (4.3%).052In-hospital mortality (PE)^2^16 (4.8%)2 (33.3%)14 (4.3%).029Death within 30 days22 (7.2%)2 (25%)20 (6.7%).107Death within 30 days (PE)^2^16 (4.8%)2 (33.3%)14 (4.3%).029Death within three months55 (19.5%)2 (25%)53 (19.3%).656Modified Rankin Scale at discharge < 4217 (65.8%)3 (37.5%)214 (66.5%).128Modified Rankin Scale at Three months < 4157 (60.6%)4 (50%)153 (61%).716BMI* body mass index, LMWH low molecular weight heparine, AC anticoagulation.^1^Categorical variables are presented with the number and percentage of patients to whom the characteristic applies, Continuous variables are presented with the mean ± the standard deviation.^2^Categorical variables are calculated using Fisher's exact test (2-sided); Continuous variables are calculated using Mann–Whitney U test (2-sided).

The original Article has been corrected.